Qiagen NV | QIA - Sales Revenues

Stock Price
29.13
Daily Change
-3.51 -10.76%
Monthly
-15.68%
Yearly
-21.98%
Q2 Forecast
31.88

Qiagen NV reported $419.22M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Akebia Therapeutics USD 57.62M 1.14M Dec/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
argenx SE USD 1.12B 132.91M Dec/2025
Avita Medical AUD 17.61M 805K Dec/2025
Dianthus Therapeutics USD 284K 112K Dec/2025
Ionis Pharmaceuticals USD 203M 46M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Moderna USD 678M 342M Dec/2025
Organon & Co USD 1.51B 90M Dec/2025
Qiagen NV USD 419.22M 38.16M Mar/2026
Revvity USD 772.06M 73.06M Dec/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.7B 60M Dec/2025
Xeris Pharmaceuticals USD 85.81M 11.43M Dec/2025